Whenever there is a Breakthrough Technology think horse and buggy/vs automobiles,electricity vs gas,telephone vs telegraph,etc) the obsolete technology ALWAYS TRYS TO destroy the new technology.

Fast forward to Brilacidin.

If 'B' works on enveloped viruses in general,(common cold,flu,etc) what will that do to the OTC and Rx markets that BP's have "enjoyed"for over 100 years?(Antibiotics,anti-inflamation drugs etc.,cough and cold remedies etc.etc.etc.)

Enter Kevetrin.Causing cancer cells/tumors to reactivate P53 and self destruct.

What does that potentially do to the Cancer/Chemo markets?

I heard back a while ago that a CEO of a BP (don't remember who) say that "they" are not in business to cure but to increase shareholder value.

Remember smallpox and polio? They were "cured"so to speak.Now how much revenue does BP reap from those disease remedies ,,,nada.

BP's don't want "cures".They want REPEAT CUSTOMERS.

BP will not welcome the IPIX pipeline with "open arms" and will lobby and do everything they can to bury IPIX.Until they can't.

Multinational trials for "B" should help keep the FDA "Honest".

Breakthrough technologies always eventually succeed.IPIX will be no different and I suspect very soon.

Kelt